BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3778556)

  • 41. The iron content of the brain of rats with choreiform movements.
    Hadzović S; Nikolin B; Stern P
    Eur J Pharmacol; 1967 Jan; 1(1):15-7. PubMed ID: 6058894
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of piperidine and related alicyclic amines on nicotinic and muscarinic agonist binding sites in the mammalian brain.
    Yamada S; Kagawa Y; Ushijima H; Takayanagi N; Hayashi E
    J Pharmacobiodyn; 1986 Jul; 9(7):620-5. PubMed ID: 3772718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absence of an effect of terfenadine on guinea pig brain histamine H1-receptors in vivo determined by receptor binding techniques.
    Wiech NL; Martin JS
    Arzneimittelforschung; 1982; 32(9a):1167-70. PubMed ID: 6817763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of stimulation or inhibition of muscarinic or nicotinic receptors on the content of biogenic amines in various parts of rat brain.
    Bień E; Herman ZS
    Acta Physiol Pol; 1983; 34(2):227-32. PubMed ID: 6141700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine.
    Roth KA; McIntire SL; Barchas JD
    J Pharmacol Exp Ther; 1982 May; 221(2):416-20. PubMed ID: 7077536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of choline with nicotinic and muscarinic cholinergic receptors in the rat brain in vitro.
    Costa LG; Murphy SD
    Clin Exp Pharmacol Physiol; 1984; 11(6):649-54. PubMed ID: 6536422
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Affinity of pyridylalkylamines for nicotinic, muscarinic and histaminic recognition sites in brain tissue preparations.
    Repond C; Pratt JA; Stolerman IP; Mayer JM; Jenner P; Marsden CD; Testa B
    Arzneimittelforschung; 1986 Aug; 36(8):1191-4. PubMed ID: 3778556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopaminergic mechanisms in the locomotor stimulant effects of nicotine.
    Clarke PB
    Biochem Pharmacol; 1990 Oct; 40(7):1427-32. PubMed ID: 2222501
    [No Abstract]   [Full Text] [Related]  

  • 49. Brain nicotine binding sites.
    Wonnacott S
    Hum Toxicol; 1987 Sep; 6(5):343-53. PubMed ID: 3315965
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.